Skip to main content Skip to page footer

Carcinoma of Unknown Primary (CUP)

Logo des NCT Heidelberg Logo des NCT Heidelberg

Carcinoma of Unknown Primary (CUP)

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Metastatic Disease: First-Line-Therapy

There are currently no studies available

Metastatic Disease: Follow-Up Treatment

Title: A phase II, open-label, randomized, multi-center study comparing the efficacy and safety of Sacituzumab govitecan (SG) versus investigators choice in patients with cancer of unknown primary (CUP) who are relapsed after or refractory to platinum-based chemotherapy
Phase: II
Contact: Madeleine Rehberger / Study Nurse
Email-Address: Madeleine.Rehberger(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Alwin Krämer
Registration: Keine Registernummer angegeben.
EU CTIS/EudraCT: Die Studie ist im EU-CTIS registriert. CTIS: 2025-523055-55-00

Cross-disciplinary Trials

Surgical Study

There are currently no studies available

Radiotherapy Study

Other study

Title: IMPULS-A: Implementierung eines Unterstützungsprogramms für Langzeitkrebsüberlebende im Alter
Phase: N/A
Contact: M. Sc. Charlotte Flock / Kontaktperson
Email-Address: IMPULS-A(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Hans-Christoph Friederich
Registration: Keine Registernummer angegeben.
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A:

Title: Randomized Comparison of Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in Patients With Advanced Rare Cancers (RATIONALE)
Phase: N/A
Contact: Elke Bauriegel / Kontaktperson
Email-Address: rationale_pm(at)nct-heidelberg.de
Clinical Investigator: Prof. Dr. med. Richard Schlenk
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT06855134
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A:

Title: NCT MASTER Plattform Molecularly Aided Stratification for Tumor Eradication Research
Phase: N/A
Contact: MASTER Studienbüro / Kontaktperson
Email-Address: master(at)nct-heidelberg.de
Clinical Investigator: Prof. Dr. med. Stefan Fröhling
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05852522
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A: